Quarterly report pursuant to Section 13 or 15(d)

Stockholders Equity (Details) - Schedule of options granted to purchase common stock

v3.22.1
Stockholders Equity (Details) - Schedule of options granted to purchase common stock
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
shares
Schedule of options granted to purchase common stock [Abstract]  
Number of Options, Outstanding at the beginning of period 4,084,549
Weighted average exercise price, Outstanding at the beginning of period (in Dollars per share) | $ / shares $ 3.95
Aggregate intrinsic value, Outstanding at the beginning of period (in Dollars) | $ $ 671
Number of Options, Granted 1,153,500
Weighted average exercise price, Granted (in Dollars per share) | $ / shares $ 1.41
Number of Options, Forfeited (88,399)
Weighted average exercise price, Forfeited (in Dollars per share) | $ / shares $ 6.38
Number of Options, Outstanding at the end of period 5,149,650
Weighted average exercise price, Outstanding at the end of period (in Dollars per share) | $ / shares $ 3.34
Aggregate intrinsic value, Outstanding at the end of period (in Dollars) | $ $ 888
Exercisable at the end of period 2,801,390
Number of Options, Weighted average remaining contractual life – years 7 years 3 months